References Stanaway JD, et al
By changing how the brain uses chemicals like dopamine, these drugs may make cravings weaker and easier to ignore
CCS/CHFS heart failure guidelines: clinical trial update on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in amyloidosis
These begin with alterations in SCFA signaling and subsequently diverge into bile acid-mediated pathways that modulate farnesoid X receptor (FXR) and Takeda G-protein-coupled receptor 5 (TGR5) activity [19 136]
doi:10.1186/1749-8546-5-14 88
Please always check product packaging, if it exists, for the ingredient list applicable to the product you're purchasing, or the brand or retailer's website for the most up-to-date ingredient list.